Harry W. Alcorn Jr., SVP, Clinical Operations at DiaMedica Therapeutics Inc. (DMAC), bought 15,000 shares at $3.80 ($57K) on 2021-09-15, disclosed to the SEC on 2021-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| DMAC | BUY | 2019-03-29 | $669 | — | Filing → |
| DMAC | BUY | 2018-12-11 | $4K | — | Filing → |